Fieldpoint Private Securities’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Fieldpoint Private Securities's RGEN Position: Q2 2022 in Review
Fieldpoint Private Securities reduced its Repligen (RGEN) stake by 62% in Q2 2022, selling an estimated $27.5K and leaving 105 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #637.
Fieldpoint Private Securities first reported a position in RGEN in Q4 2020 and has held it in 7 quarters since. The position peaked at $75K in Q3 2021. 405 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.
- Fieldpoint Private Securities held 105 shares of Repligen worth $17K as of Q2 2022.
- Fieldpoint Private Securities sold 174 Repligen shares in Q2 2022, an estimated $27.5K.
- Repligen made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #637 holding.
- Fieldpoint Private Securities first reported a position in Repligen in Q4 2020 and has held it in 7 quarters since.
- Fieldpoint Private Securities's Repligen position peaked at $75K in Q3 2021.
- 405 funds tracked by Wall St. Rank held Repligen as of Q2 2022.
Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.